Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Sexual Dysfunctions, PsychologicalHypoactive Sexual Desire DisorderErectile Dysfunctions
Interventions
DRUG

Bupropion hydrochloride sustained-release

Up to 70 eligible patients will be randomly assigned to Bupropion Hydrochloride Sustained-Release or placebo treatment groups in a 1:1 ratio using a computer-generated table of random numbers through the use of the Randomization.com program. Subjects will be randomized to to Bupropion Hydrochloride Sustained-Release 150mg b.d. (n = 35) or placebo b.d (n = 35)The study drug will be repacked in the standard capsules by the research assistant who is not involved in the assessment of the study. The study drug and placebo will be packaged in sets of 11 (1 tablet per day for 3 days, followed by 2 tablets per day for 4 days.) for the first week. Subsequently, the study drug and placebo will be packaged in sets of 14 (2 tablets per day for 7 days.).

DRUG

placebo

Up to 70 eligible patients will be randomly assigned to Bupropion Hydrochloride Sustained-Release or placebo treatment groups in a 1:1 ratio using a computer-generated table of random numbers through the use of the Randomization.com program. Subjects will be randomized to to Bupropion Hydrochloride Sustained-Release 150mg b.d. (n = 35) or placebo b.d (n = 35)

Trial Locations (1)

59100

University Malaya Medical Center, Kuala Lumpur

All Listed Sponsors
lead

University of Malaya

OTHER

NCT02593396 - Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men | Biotech Hunter | Biotech Hunter